Abdominal Obesity-Metabolic Syndrome Quantitative Trait Locus 2 (AOMS2)

Abdominal Obesity-Metabolic Syndrome Quantitative Trait Locus 2, also known as abdominal obesity-metabolic syndrome, is related to abdominal obesity-metabolic syndrome 1 and cardiovascular system disease, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Abdominal Obesity-Metabolic Syndrome Quantitative Trait Locus 2 is AOMS1 (Abdominal Obesity-Metabolic Syndrome QTL1), and among its related pathways/superpathways are Metabolism and IL-9 Signaling Pathways. The drugs Cilostazol and Dopamine have been mentioned in the context of this disorder. Affiliated tissues include liver and endothelial, and related phenotypes are hypertension and abdominal obesity